Barshop Institute for Longevity and Aging Studies, UT Health San Antonio (UTHSCSA), SA, TX, United States of America; Department of Cell Systems and Anatomy, UTHSCSA, SA, TX, United States of America.
Division of Geriatrics, Gerontology, and Palliative Medicine, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE, United States of America.
Biochim Biophys Acta Gene Regul Mech. 2023 Sep;1866(3):194957. doi: 10.1016/j.bbagrm.2023.194957. Epub 2023 Jun 22.
The loss of proteostasis due to reduced efficiency of protein degradation pathways plays a key role in multiple age-related diseases and is a hallmark of the aging process. Paradoxically, we have previously reported that the Caenorhabditis elegans rpn-10(ok1865) mutant, which lacks the RPN-10/RPN10/PSMD4 subunit of the 19S regulatory particle of the 26S proteasome, exhibits enhanced cytosolic proteostasis, elevated stress resistance and extended lifespan, despite possessing reduced proteasome function. However, the response of this mutant against threats to endoplasmic reticulum (ER) homeostasis and proteostasis was unknown. Here, we find that the rpn-10 mutant is highly ER stress resistant compared to the wildtype. Under unstressed conditions, the ER unfolded protein response (UPR) is activated in the rpn-10 mutant as signified by increased xbp-1 splicing. This primed response appears to alter ER homeostasis through the upregulated expression of genes involved in ER protein quality control (ERQC), including those in the ER-associated protein degradation (ERAD) pathway. Pertinently, we find that ERQC is critical for the rpn-10 mutant longevity. These changes also alter ER proteostasis, as studied using the C. elegans alpha-1 antitrypsin (AAT) deficiency model, which comprises an intestinal ER-localised transgenic reporter of an aggregation-prone form of AAT called ATZ. The rpn-10 mutant shows a significant reduction in the accumulation of the ATZ reporter, thus indicating that its ER proteostasis is augmented. Via a genetic screen for suppressors of decreased ATZ aggregation in the rpn-10 mutant, we then identified ecps-2/H04D03.3, a novel ortholog of the proteasome-associated adaptor and scaffold protein ECM29/ECPAS. We further show that ecps-2 is required for improved ER proteostasis as well as lifespan extension of the rpn-10 mutant. Thus, we propose that ECPS-2-proteasome functional interactions, alongside additional putative molecular processes, contribute to a novel ERQC adaptation which underlies the superior proteostasis and longevity of the rpn-10 mutant.
由于蛋白质降解途径效率降低导致的蛋白质稳态丧失在多种与年龄相关的疾病中起着关键作用,是衰老过程的标志。矛盾的是,我们之前曾报道过,缺乏 26S 蛋白酶体 19S 调节颗粒的 RPN-10/RPN10/PSMD4 亚基的秀丽隐杆线虫 rpn-10(ok1865)突变体表现出增强的细胞质蛋白质稳态、提高的应激抗性和延长的寿命,尽管其蛋白酶体功能降低。然而,这种突变体对内质网 (ER) 稳态和蛋白质稳态威胁的反应尚不清楚。在这里,我们发现 rpn-10 突变体与野生型相比具有很强的 ER 应激抗性。在未受应激的情况下,rpn-10 突变体中的内质网未折叠蛋白反应 (UPR) 被激活,这表现为 xbp-1 剪接增加。这种启动反应似乎通过上调参与内质网蛋白质质量控制 (ERQC) 的基因的表达来改变内质网稳态,包括内质网相关蛋白降解 (ERAD) 途径中的基因。相关地,我们发现 ERQC 对于 rpn-10 突变体的长寿至关重要。这些变化也改变了 ER 蛋白质稳态,这可以通过使用秀丽隐杆线虫 α-1 抗胰蛋白酶 (AAT) 缺乏模型来研究,该模型包含一种聚集倾向形式的 AAT 的肠内质网定位的转基因报告器,称为 ATZ。rpn-10 突变体中 ATZ 报告器的积累显著减少,这表明其 ER 蛋白质稳态得到增强。通过对 rpn-10 突变体中降低的 ATZ 聚集的抑制因子进行遗传筛选,我们随后鉴定出 ecps-2/H04D03.3,这是蛋白酶体相关接头和支架蛋白 ECM29/ECPAS 的一个新的同源物。我们进一步表明,ecps-2 是改善 rpn-10 突变体的 ER 蛋白质稳态以及延长其寿命所必需的。因此,我们提出 ECPS-2-蛋白酶体功能相互作用以及其他潜在的分子过程有助于一种新的 ERQC 适应,这是 rpn-10 突变体优越的蛋白质稳态和长寿的基础。